Maravai
Careers Portfolio Contact us
Welcome Agenda & Webcast Replay Speaker Bios Videos Supporting Documents
Who we are Leadership Board of Directors Corporate Social Responsibility Maravai Foundation
Investors Overview News & Events Company Info Financial Info Stock Data SEC Filings ESG Governance
Skip to main content Skip to section navigation Skip to footer
Maravai
Who we are Who we are Leadership Board of Directors Corporate Social Responsibility Maravai Foundation Investors Overview News & Events Company Info Financial Info Stock Data SEC Filings ESG Governance Careers Portfolio Contact us
Welcome Agenda & Webcast Replay Speaker Bios Videos Supporting Documents

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Executive Team
    • Contacts
    • FAQ
  • Financial Info
    • Quarterly Results
    • Annual Reports & Proxy Statements
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
  • ESG
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Whistleblower Policy
  • News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
Feb 01, 2023 8:00am EST

Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023

Dec 01, 2022 4:01pm EST

Maravai LifeSciences Announces Updated CEO Leadership Transition Plans

Nov 16, 2022 5:05pm EST

Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America

Nov 07, 2022 4:10pm EST

New Kit Predicts Retroviral Particle Clearance in Biopharmaceutical Manufacturing

Nov 03, 2022 4:05pm EDT

Maravai LifeSciences Announces November and December 2022 Investor Conference Schedule

Nov 02, 2022 4:05pm EDT

Maravai LifeSciences Reports Third Quarter 2022 Financial Results

Oct 19, 2022 8:10am EDT

Maravai LifeSciences Temporarily Reinstates Carl Hull as CEO Amidst Pending Noncompetition Litigation

Oct 18, 2022 4:15pm EDT

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022

Oct 03, 2022 4:05pm EDT

Maravai LifeSciences Announces CEO Leadership Transition

Sep 13, 2022 8:00am EDT

TriLink BioTechnologies, Part of Maravai LifeSciences, Expands its mRNA Raw Material Offering with the First GMP-grade Modified Nucleoside-Triphosphate Product

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
Maravai LifeSciences
10770 Wateridge Circle Suite 200
San Diego, CA 92121

Privacy Notice

PO Terms

Copyright © 2023 Maravai LifeSciences Holdings, Inc.
Maravai
Maravai
info@maravai.com
Hours
 

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.